DV Biomed CoROCO:6539 -2.61%67 Days Payable is 70.22 as of Dec. 2025, which is 31% above its 10-year median of 53.41. GuruFocus rates ROCO:6539 with a GF Score™ of 67/100 and a GF Value™ of NT$70.30 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 922 Drug Manufacturers companies, DV Biomed Co ranks worse than 63.02% on this metric.
The historical rank and industry rank for DV Biomed Co's Days Payable or its related term are showing as below:
ROCO:6539'
s Days Payable Range Over the Past 10 Years
Min: 29.95 Med: 53.41 Max: 74.5
Current: 66.29
During the past 13 years, DV Biomed Co's highest Days Payable was 74.50. The lowest was 29.95. And the median was 53.41.
ROCO:6539's Days Payable is ranked worse than 63.02% of 922
companies
in the Drug Manufacturers industry
Industry Median: 90.61
vs ROCO:6539: 66.29
DV Biomed Co's Days Payable
increased
from Dec. 2024 (53.49) to Dec. 2025 (70.22).
It may suggest that DV Biomed Codelayed paying its suppliers.
DV Biomed Co Days Payable Related Terms
DV Biomed Co Days Payable Historical Data
* Premium members only.
The historical data trend for DV Biomed Co's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, DV Biomed Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DV Biomed Co Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, DV Biomed Co's Days Payable distribution charts can be found below:
* The bar in red indicates where DV Biomed Co's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
DV Biomed Co's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DV Biomed Co (ROCO:6539) has a Days Payable of 70.22 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on DV Biomed Co and its competitors. This is 31% above median its historical median of 53.41. Over the past decade, DV Biomed Co's Days Payable has ranged from 29.95 to 74.50. According to the industry distribution chart, DV Biomed Co ranks #581 out of 922 companies in the Drug Manufacturers industry, placing it in the top 63%.
Is DV Biomed Co's Days Payable too high?
DV Biomed Co's current Days Payable of 70.22 is 31% above median its 10-year median of 53.41. Over the past 10 years, this metric has ranged from a low of 29.95 to a high of 74.50. The Drug Manufacturers industry median Days Payable is 90.61. DV Biomed Co's value of 70.22 is 22.5% below this industry median. Based on the distribution chart, DV Biomed Co ranks #581 out of 922 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, DV Biomed Co has a GF Score™ of 67/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does DV Biomed Co's Days Payable compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, DV Biomed Co ranks #581 out of 922 companies for Days Payable. This places DV Biomed Co in the lower half of its industry. The industry median Days Payable is 90.61. DV Biomed Co's value of 70.22 is 22.5% below this benchmark. Historically, DV Biomed Co's own Days Payable has ranged from 29.95 to 74.50 over the past decade. While the company's 10-year median is 53.41 vs. the industry median of 90.61, DV Biomed Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.61, based on 922 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. DV Biomed Co's current Days Payable of 70.22 is 22.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on DV Biomed Co and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DV Biomed Co's current Days Payable is 70.22, which is 31% above median its own 10-year median of 53.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DV Biomed Co stock overvalued right now?
Based on GuruFocus' analysis, DV Biomed Co (ROCO:6539) is currently considered Possible Value Trap. The stock's GF Value™ is NT$70.30, compared to a current price of NT$41.00 — trading 41.7% below its estimated fair value. The current Days Payable is 70.22, which is 31% above median its 10-year median of 53.41 and 22.5% below the Drug Manufacturers industry median of 90.61. DV Biomed Co's overall GF Score™ is 67/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For DV Biomed Co (ROCO:6539), the current Days Payable is 70.22 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is DV Biomed Co (ROCO:6539) Overvalued in 2026?
Based on GuruFocus' analysis, DV Biomed Co stock appears to be undervalued.
The current stock price of NT$41.00 is trading 41.7% below its estimated GF Value™ of NT$70.30.
GuruFocus considers DV Biomed Co to be Possible Value Trap.
Key valuation signals for ROCO:6539:
Days Payable: 70.22 (31% above median its 10-year median of 53.41)
GF Value™: NT$70.30 vs. price of NT$41.00 (41.7% below fair value)
Industry Position: 22.5% below the Drug Manufacturers median (#581 of 922)
No single metric tells the full story. See the ROCO:6539 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
DV Biomed Co Ltd provides medical supplies, skincare, and healthcare products. Its products include Perfectin and L'AMOUR Isis. The company also provides medical materials and needles (medicine), and healthcare products.
67GF Score
Get the complete analysis for ROCO:6539
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6539 has been successfully added to your 
